priors.science/reviews/copd-pharmacotherapy

COPD Pharmacotherapy

The current evidence on 14 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty: how firmly the literature supports the claim as stated.

16claims tracked
14assessed
142primary papers reviewed
23 Oct 2026latest evidence review
3 Established · 7 Likely · 1 Uncertain · 2 Doubtful · 1 Refuted  |  four-reviewer panel · PICO Framework
ClaimStandingEvidence certaintyCorpus
Dupilumab cuts exacerbationsBiologicsEstablished90%10
Inhaled corticosteroids raise pneumonia riskIcs RiskEstablished86%11
Triple therapy cuts exacerbationsTriple TherapyEstablished86%16
Mepolizumab in eosinophilic chronic obstructive pulmonary diseaseBiologicsLikely83%10
Dual bronchodilation improves FEV1BronchodilatorsLikely82%10
Azithromycin reduces exacerbationsExacerbation ManagementEarly evidenceLikely80%10
Long-acting muscarinic antagonist plus beta-agonist vs beta-agonist plus inhaled corticosteroid exacerbationsBronchodilatorsLong-standingLikely78%9
Ensifentrine add-on therapyEmerging TherapiesLikely74%7thin basis
Roflumilast in severe chronic obstructive pulmonary diseaseExacerbation ManagementLikely74%10
Eosinophils predict inhaled corticosteroid responseIcs RiskLikely72%9
Single-inhaler triple therapy adherenceTriple TherapyEarly evidenceUncertain64%14
Triple therapy mortality benefitTriple TherapyEarly evidenceDoubtful42%11
Tezepelumab in chronic obstructive pulmonary diseaseEmerging TherapiesDoubtful32%22thin basis
Inhaled corticosteroid withdrawal and exacerbationsIcs RiskRefuted27%11
Track COPD Pharmacotherapy.
These claims are re-checked against new research as it is published. Track this topic for the full review, including each claim’s challenge and the papers behind it.
Track this topic →
Standing: what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely70–84%Well supported, with some gaps or indirect evidence.
Uncertain50–69%Mixed or limited evidence. Genuinely open.
Doubtful30–49%Little support; the weight of evidence leans against it.
Refuted< 30%The evidence contradicts it. Confidently false as stated.
A standing changes only when the score moves past a boundary by more than 4 points, the re-scoring noise floor; a score within 4 points of a boundary keeps its previous standing.
Where the evidence sits in time
Early evidenceMost of this evidence is from the last two years.
Long-standingMost of this evidence is older than the rest of this field.